{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:20:32Z","timestamp":1788254432532,"version":"build-2803163510"},"reference-count":40,"publisher":"SAGE Publications","issue":"3_suppl","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Cosmetic Ingredient Review"},{"name":"Personal Care Products Council"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Int J Toxicol"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>The Expert Panel for Cosmetic Ingredient Safety (Panel) assessed the safety of Polyhydroxystearic Acid, Poly(3-Hydroxyoctanoic Acid), and Polylactic Acid as used in cosmetic formulations. These ingredients are reported to function in cosmetics as a non-surfactant dispersing agent, a skin-conditioning agent, and an abrasive agent, respectively. The Panel reviewed the available data to determine the safety of these ingredients and concluded that these ingredients are safe in cosmetics in the present practices of use and concentrations described in this safety assessment.<\/jats:p>","DOI":"10.1177\/10915818261469141","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T03:52:49Z","timestamp":1784865169000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety Assessment of Polyhydroxystearic Acid, Poly(3-Hydroxyoctanoic Acid), and Polylactic Acid as Used in Cosmetics"],"prefix":"10.1177","volume":"45","author":[{"given":"Preethi S.","family":"Raj","sequence":"first","affiliation":[{"name":"Cosmetic Ingredient Review Former Senior Scientific Analyst\/Writer"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma F.","family":"Bergfeld","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald V.","family":"Belsito","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis D.","family":"Klaassen","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Liebler","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan E.","family":"Rettie","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ross","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Slaga","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Former Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan C.","family":"Tilton","sequence":"additional","affiliation":[{"name":"Expert Panel for Cosmetic Ingredient Safety Member"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monice M.","family":"Fiume","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Senior Director"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Heldreth","sequence":"additional","affiliation":[{"name":"Cosmetic Ingredient Review Executive Director"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"International Cosmetic Ingredient Dictionary (Dictionary)","author":"Personal Care Products Council","year":"2023","unstructured":"Personal Care Products Council. International Cosmetic Ingredient Dictionary (Dictionary). Washington, DC: Personal Care Products Council; 2023. https:\/\/incipedia.personalcarecouncil.org. Accessed 02\/06\/2023."},{"key":"e_1_3_3_3_2","first-page":"1","article-title":"Amended final report on the safety assessment of hydroxystearic acid","volume":"18","author":"Andersen FA","year":"1999","unstructured":"Andersen FA, ed. Amended final report on the safety assessment of hydroxystearic acid. Int J Toxicol. 1999;18:1-10.","journal-title":"Int J Toxicol"},{"key":"e_1_3_3_4_2","doi-asserted-by":"crossref","unstructured":"Burnett CL Bergfeld WF Belsito DV et al. Safety assessment of fatty acids & fatty acid salts as used in cosmetics 2019. Available from CIR. https:\/\/www.cir-safety.org\/ingredients","DOI":"10.1177\/1091581819836089"},{"issue":"1","key":"e_1_3_3_5_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/109158189801700101","article-title":"Final report on the safety assessment of glycolic acid, ammonium, calcium, potassium, and sodium glycolates, methyl, ethyl, propyl, and butyl glycolates, and lactic acid, ammonium, calcium, potassium, sodium, and tea-lactates, methyl, ethyl, isopropyl, and butyl lactates, and lauryl, myristyl, and cetyl lactates","volume":"17","author":"Andersen FA","year":"1998","unstructured":"Andersen FA, ed. Final report on the safety assessment of glycolic acid, ammonium, calcium, potassium, and sodium glycolates, methyl, ethyl, propyl, and butyl glycolates, and lactic acid, ammonium, calcium, potassium, sodium, and tea-lactates, methyl, ethyl, isopropyl, and butyl lactates, and lauryl, myristyl, and cetyl lactates. Int J Toxicol. 1998;17(1 suppl):1-241.","journal-title":"Int J Toxicol"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1091581817726742"},{"key":"e_1_3_3_7_2","unstructured":"National Library of Medicine. PubChem: 12-hydroxyoctadecanoic acid (polyhydroxystearic acid; CAS no. 27924-99-8). 2022. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/12-Hydroxyoctadecanoic-acid#section=Chemical-and-Physical-Properties. Accessed 11\/15\/2021."},{"key":"e_1_3_3_8_2","unstructured":"Phoenix Chemical Inc. Pelemol\u00ae PHS-8 (INCI: polyhydroxystearic acid): molecular weight information. 2021;(Unpublished data submitted by Personal Care Products Council on April 11 2022)."},{"key":"e_1_3_3_9_2","unstructured":"National Center for Biotechnology Information. PubChem annotation record for polylactic acid. Source: Hazardous Substances Data Bank (HSDB). https:\/\/pubchem.ncbi.nlm.nih.gov\/source\/hsdb\/8244. Accessed 08\/17\/2022."},{"key":"e_1_3_3_10_2","unstructured":"Phoenix Chemical Inc. Pelemol\u00ae PHS-8 (INCI: polyhydroxystearic acid). 2022;(Unpublished data submitted by Personal Care Products Council on April 11 2022.)."},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.5772\/23927"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.06.012"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25215023"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.polymer.2016.07.018"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.01869-08"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.3390\/polym13111822"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/bm101302t"},{"issue":"12","key":"e_1_3_3_18_2","first-page":"51","article-title":"Recent applications of polylactic acid in pharmaceutical and medical industries","volume":"7","author":"Abd Alsaheb RA","year":"2015","unstructured":"Abd Alsaheb RA, Aladdin A, Othman NZ, et al. Recent applications of polylactic acid in pharmaceutical and medical industries. J Chem Pharmaceut Res. 2015;7(12):51-63.","journal-title":"J Chem Pharmaceut Res"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-03287-5_13"},{"key":"e_1_3_3_20_2","unstructured":"U.S. Food and Drug Administration Center for Food Safety & Applied Nutrition (CFSAN). Voluntary cosmetic registration program - Frequency of use of cosmetic ingredients (VCRP). Obtained Under the Freedom of Information Act from CFSAN; requested as \u201cfrequency of use data\u201d. 2023;Received February 2 2023."},{"key":"e_1_3_3_21_2","unstructured":"Personal Care Products Council. Concentration of use by FDA product category: polyhydroxystearic acid and related ingredients. 2021;(Unpublished data submitted by Personal Care Products Council on July 6 2021)."},{"key":"e_1_3_3_22_2","unstructured":"European Commission. CosIng database; following cosmetic regulation no. 1223\/2009. 2020. https:\/\/ec.europa.eu\/growth\/tools-databases\/cosing\/. Accessed: 2\/5\/2022."},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","unstructured":"European Food Safety Authority. Scientific opinion on the safety evaluation of the substance poly(12-hydroxystearic acid) stearate CAS no. 58128-22-6 for use in food contact materials. Parma Italy. 2010. doi:10.2903\/j.efsa.2010.1520. Accessed February 10 2022.","DOI":"10.2903\/j.efsa.2010.1520"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","unstructured":"European Food Safety Authority. Scientific opinion on the safety evaluation of the substance glycolic acid for use in food contact materials. Parma Italy. 2010. doi:10.2903\/j.efsa.2010.1927. Accessed February 10 2022.","DOI":"10.2903\/j.efsa.2010.1927"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40005-019-00443-1"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2016.04.019"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/5834418"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2019.0169"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/0142-9612(96)85754-1"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10266-021-00683-4"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.injury.2020.12.015"},{"key":"e_1_3_3_32_2","unstructured":"U.S. Food and Drug Administration (FDA). Devices@FDA. 2022. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/devicesatfda\/index.cfm. Accessed March 4 2022."},{"key":"e_1_3_3_33_2","unstructured":"U.S. Food and Drug Administration (FDA). Product classification. 2022. https:\/\/www.accessdata.fda.gov\/scripts\/cdrh\/cfdocs\/cfPCD\/PCDSimpleSearch.cfm. Accessed March 4 2022."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.1966.01330050143023"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxlet.2014.11.032"},{"issue":"8","key":"e_1_3_3_36_2","first-page":"1357","article-title":"Evaluation of biocompatibility and toxicity of biodegradable poly (DL-lactic acid) films","volume":"7","author":"Li RY","year":"2015","unstructured":"Li RY, Liu ZG, Liu HQ, Chen L, Liu JF, Pan YH. Evaluation of biocompatibility and toxicity of biodegradable poly (DL-lactic acid) films. Am J Transl Res. 2015;7(8):1357-1370.","journal-title":"Am J Transl Res"},{"issue":"12","key":"e_1_3_3_37_2","first-page":"1551","article-title":"Evaluation of tissue response and genotoxicity of poly(L\/D-lactic acid) disks implanted in rat calvarium","volume":"27","author":"G\u00f6elzer J","year":"2012","unstructured":"G\u00f6elzer J, Avelar R, Dolzan A, et al. Evaluation of tissue response and genotoxicity of poly(L\/D-lactic acid) disks implanted in rat calvarium. Histol Histopathol. 2012;27(12):1551-1557.","journal-title":"Histol Histopathol"},{"key":"e_1_3_3_38_2","unstructured":"AMA Laboratories. 50 human subject repeat insult patch test skin irritation\/sensitization evaluation (occlusive patch) Pelemol\u00ae PHS-8 (INCI: polyhydroxystearic acid). 2003;(Unpublished data submitted by Personal Care Products Council on April 11 2022)."},{"key":"e_1_3_3_39_2","unstructured":"Anonymous. Modified Marzulli-Maibach protocol - human repeated insult patch test with challenge (product contains 3.45% polyhydroxystearic acid). 2021;(Unpublished data submitted by the Personal Care Products Council on April 15 2022)."},{"key":"e_1_3_3_40_2","unstructured":"Anonymous. Repeated insult patch test (RIPT) - Marzulli Maibach method (product contains 4% polylactic acid). 2014;(Unpublished data submitted by Personal Care Products Council on April 15. 2022)."},{"issue":"1","key":"e_1_3_3_41_2","first-page":"000120","article-title":"Injectable Poly-D, L-lactic acid in facial rejuvenation: three case reports","volume":"4","author":"Lin J-Y","year":"2020","unstructured":"Lin J-Y, Lin C-Y. Injectable Poly-D, L-lactic acid in facial rejuvenation: three case reports. J Cosmetol. 2020;4(1):000120.","journal-title":"J Cosmetol"}],"container-title":["International Journal of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10915818261469141","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10915818261469141","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10915818261469141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:05:21Z","timestamp":1788253521000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10915818261469141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":40,"journal-issue":{"issue":"3_suppl","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/10915818261469141"],"URL":"https:\/\/doi.org\/10.1177\/10915818261469141","relation":{},"ISSN":["1091-5818","1092-874X"],"issn-type":[{"value":"1091-5818","type":"print"},{"value":"1092-874X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]}}}